TRISENOX

This brand name is authorized in Austria, Brazil, Canada, Cyprus, Estonia, Spain, Finland, France, Ireland, Japan, Lithuania, Netherlands, Poland, Romania, Turkey, United Kingdom, United States

Active ingredients

The drug TRISENOX contains one active pharmaceutical ingredient (API):

1 Arsenic trioxide
UNII S7V92P67HO - ARSENIC TRIOXIDE

Arsenic trioxide causes morphological changes and deoxyribonucleic acid (DNA) fragmentation characteristic of apoptosis in NB4 human promyelocytic leukaemia cells in vitro. Arsenic trioxide also causes damage or degradation of the fusion protein PML/RAR alpha.

Read about Arsenic trioxide

Medication package inserts

Below package inserts are available for further reading:

Title Information Source Document Type  
TRISENOX Concentrate for solution for infusion European Medicines Agency (EU) MPI, EU: SmPC

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code Group title Classification
L01XX27 Arsenic trioxide L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01X Other antineoplastic agents → L01XX Other antineoplastic agents
Discover more medicines within L01XX27

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
Country: BR Câmara de Regulação do Mercado de Medicamentos Identifier(s): 537518050007217
Country: CA Health Products and Food Branch Identifier(s): 02407833, 02480387
Country: EE Ravimiamet Identifier(s): 1202566, 1797699
Country: ES Centro de información online de medicamentos de la AEMPS Identifier(s): 102204002
Country: FI Lääkealan turvallisuus- ja kehittämiskeskus Identifier(s): 499695
Country: FR Base de données publique des médicaments Identifier(s): 61128000
Country: GB Medicines & Healthcare Products Regulatory Agency Identifier(s): 385915
Country: JP 医薬品医療機器総合機構 Identifier(s): 4291409A1026, 4291409A2022
Country: LT Valstybinė vaistų kontrolės tarnyba Identifier(s): 1031455, 1087929
Country: NL Z-Index G-Standaard Identifier(s): 14750368
Country: NL Z-Index G-Standaard, PRK Identifier(s): 201979, 61522
Country: PL Rejestru Produktów Leczniczych Identifier(s): 100131957, 100421030, 100427362
Country: RO Agenția Națională a Medicamentului și a Dispozitivelor Medicale Identifier(s): W62932001, W65972001
Country: TR İlaç ve Tıbbi Cihaz Kurumu Identifier(s): 8699638764143
Country: US FDA, National Drug Code Identifier(s): 63459-600, 63459-601

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.